跳至主要内容
临床试验/ITMCTR2022000012
ITMCTR2022000012尚未招募1 期

Clinical efficacy of Wendanningxin granule in the treatment of mild to moderate anxiety

Guang'anmen Hospital, Chian Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • (1) Age: 18 ~ 65 years old, both male and female;
  • (2) Conform to the diagnostic criteria of anxiety disorder in western medicine and the diagnostic criteria of heart and gall Qi deficiency syndrome;
  • (3) At the time of enrollment, the total score of HAMA Anxiety Scale (17 items) was = 14 and = 29;
  • (4) The total score of HAMD depression scale = 7 at the time of enrollment;
  • (5) Informed consent and sign the informed consent form.

排除标准

  • (1) Those with suicidal tendencies;
  • (2) Severe anxiety (HAMA total score >29);
  • (3) Anxiety attack secondary to other mental or physical diseases and accompanied by severe psychotic symptoms;
  • (4) Patients with severe diseases of other systems and severe heart, liver and kidney dysfunction (including ALT and AST 1.5 times higher than normal);
  • (5) Those who had taken anti anxiety agents within four weeks before enrollment;
  • (6) Pregnancy or lactation or pregnancy; Women of childbearing age with positive urine pregnancy test;
  • (7) Known alcoholics or drug addicts.

研究者

发起方
Guang'anmen Hospital, Chian Academy of Chinese Medical Sciences

相似试验